[TNFα induced IL-8 production through p38 MAPK- NF-kB pathway in human hepatocellular carcinoma cells]

Yao-hui Wang1, Jing-lin Xia, Wei-min Wang

  • 1Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Abstract

Insights

Tumor necrosis factor-alpha (TNF-α) increases interleukin-8 (IL-8) production in liver cancer cells. The p38 mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-kB) pathways are key regulators of this process.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Oncology

Context:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Interleukin-8 (IL-8) is a pro-inflammatory cytokine implicated in cancer progression.
  • Tumor necrosis factor-alpha (TNF-α) is a key mediator in inflammation and immunity.

Purpose:

  • To elucidate the role of the p38 MAPK-NF-kB signaling pathway in TNF-α-induced IL-8 production.
  • To investigate the molecular mechanisms underlying IL-8 regulation in human HCC cells (MHCC-97H).

Summary:

  • TNF-α significantly upregulated IL-8 production in MHCC-97H cells in a time- and dose-dependent manner.
  • TNF-α stimulation led to increased phosphorylation of p38 MAPK and nuclear translocation of NF-kB p65.
  • Inhibition of p38 MAPK (using SB203580) reduced IL-8 production and partially inhibited NF-kB p65 nuclear translocation.

Impact:

  • This study identifies the p38 MAPK-NF-kB pathway as a critical regulator of IL-8 production in HCC.
  • Understanding this pathway offers potential therapeutic targets for managing HCC-associated inflammation and progression.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...